Salivary penetration of moxalactam
Casto, D.T.; Gal, P.; McCue, J.D.; Zumwalt, A.A.
Clinical Pharmacy 4(1): 67-70
1985
ISSN/ISBN: 0278-2677 PMID: 3971685 Document Number: 246672
Document emailed within 1 workday
Related Documents
Polk, R.; Hume, A.; Kline, B.J.; Cardea, J. 1983: Penetration of moxalactam and cefazolin into bone following simultaneous bolus or infusion Clinical Orthopaedics and Related Research 177: 216-221Tokuda, H.; Hatano, H. 1973: Studies on the penetration of antibiotics into the tear. I. the penetration of cephaloridine, cephapirin and kanamycin into the tear Nippon Ganka Gakkai Zasshi 77(9): 1168-1174
Cuena Boy, R.; Azanza Perea, J.R.; Honorato Pérez, J. 1983: Moxalactam Revista de Medicina de la Universidad de Navarra 27(1): 45-46
Bothra, A.C.; Agarwal, R.K.; Dube, M.K.; Bothra, S.; Dixit, S.M. 1977: Mixed salivary tumor in heterotopic salivary tissue at the base of the neck International Surgery 62(4): 228-229
Situ, Z.Q. 1990: Distribution of intermediate filaments in the salivary glands and salivary gland tumors Zhonghua Kou Qiang Yi Xue Za Zhi 25(5): 262-264; 317
Sirsat, A.V.; Talavdekar, R.V.; Sanghvi, V.D.; Rajpal, R.M. 1984: Salivary amylase and isoamylase composition in benign and malignant diseases of salivary gland. A preliminary report Indian Journal of Cancer 21(4): 119-121
Reed, M.D.; Bertino, J.S.; Aronoff, S.C.; Speck, W.T.; Blumer, J.L. 1982: Evaluation of moxalactam Clinical Pharmacy 1(2): 124-134
Herbert, D.A. 1982: Claims for moxalactam Annals of Internal Medicine 97(5): 787-788
Hofstetter, A. 1982: Moxalactam (lamoxactam) Der Urologe. Ausg. a 21(4): 239-240
Pippi, R.; Patini, R.; Ghiciuc, C.M.; Sandu, R.B.; Pasquali, V.; Scaccianoce, S.; Dima-Cozma, L.C.; Patacchioli, F.R. 2014: Diurnal trajectories of salivary cortisol, salivary α-amylase and psychological profiles in oral lichen planus patients Journal of Biological Regulators and Homeostatic Agents 28(1): 147-156
Ericson, S.; Sjöbäck, I. 1996: Salivary factors in children with recurrent parotitis. Part 1: Salivary flow rate, buffering capacity and inorganic components Swedish Dental Journal 20(4): 121-132
Brands, T. 1973: Radiographic diagnosis of salivary gland diseases with special reference to animal experiments and salivary electrolytes and saliva electrophoreses Hippokrates 44(4): 437-444
Chabbert, Y.A. 1983: Moxalactam: preclinical evaluation La Semaine des Hopitaux: Organe Fonde Par l'Association d'Enseignement Medical des Hopitaux de Paris 59(26): 1943-1946
Fourtillan, J.B. 1983: Moxalactam: a new group of beta-lactams La Semaine des Hopitaux: Organe Fonde Par l'Association d'Enseignement Medical des Hopitaux de Paris 59(26): 1947-1948
Kelentey, B.A.; Kelentey, B.J. 1987: Secretion of cefsulodin and moxalactam in the saliva Fogorvosi Szemle 80(6): 183-185
Pajchel, G.; Borowiecka, B.; Chojnowski, W. 1992: Determination of moxalactam, aztreonam and imipenem by the perchloric hydroxylamine method Acta Poloniae Pharmaceutica 49(1-2): 7-10
Baumgärtner, M.; Dickgiesser, N.; Müller, S.; Wundt, W. 1981: Moxalactam and cefotaxime--two new beta-lactam antibiotics compared with three well-known cephalosporins Arzneimittel-Forschung 31(10): 1677-1681
Soback, S. 1989: Pharmacokinetics of single-dose administration of moxalactam in unweaned calves American Journal of Veterinary Research 50(4): 498-501
Orsal, E.; Seven, B.; Keles, M.; Ayan, A.K.; Cankaya, E.; Ozkan, O. 2013: Assessment of salivary gland function in patients after successful kidney transplantation using (99m)Tc-pertechnetate salivary gland scintigraphy Hellenic Journal of Nuclear Medicine 16(2): 107-110
Stutman, H.R.; Parker, K.M.; Marks, M.I. 1985: Potential of moxalactam and other new antimicrobial agents for bilirubin-albumin displacement in neonates Pediatrics 75(2): 294-298